Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 25, 2003, Pages 14742-14747

  Nusinzon, Inna ^a   Horvath, Curt M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; INTERFERON; RNA; SMALL INTERFERING RNA; STAT1 PROTEIN; STAT2 PROTEIN; TRICHOSTATIN A;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEACETYLATION; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TIME SERIES ANALYSIS; TRANSCRIPTION INITIATION; VIRUS IMMUNITY;

ACETYLATION; ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE; CELL NUCLEUS; CHROMATIN; CYTOKINES; DIMERIZATION; DNA; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, REPORTER; HELA CELLS; HISTONE DEACETYLASES; HISTONES; HUMANS; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERON-STIMULATED GENE FACTOR 3; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; PLASMIDS; PRECIPITIN TESTS; RNA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; VIRUS DISEASES;

ANIMALIA;

EID: 0344304443     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.2433987100     Document Type: Article

References (39)

1. Cheung, W. L., Briggs, S. D. & Allis, C. D. (2000) Curr. Opin. Cell Biol. 12, 326-333.
2. Roth, S. Y., Denu, J. M. & Allis, C. D. (2001) Annu. Rev. Biochem. 70, 81-120.
3. Jenuwein, T. & Allis, C. D. (2001) Science 293, 1074-1080.
4. Struhl, K. (1998) Genes Dev. 12, 599-606.
5. Chambers, A. E., Banerjee, S., Chaplin, T., Dunne, J., Debernardi, S., Joel, S. P. & Young, B. D. (2003) Eur. J. Cancer 39, 1165-1175.
6. Levy, D. E. & Darnell, J. E., Jr. (2002) Nat. Rev. Mol. Cell Biol. 3, 651-662.
7. Samuel, C. E. (2001) Clin. Microbiol. Rev. 14, 778-809.
8. Biron, C. A. (2001) Immunity 14, 661-664.
9. Horvath, C. M. (2000) Trends Biochem. Sci. 25, 496-502.
10. Darnell, J. E., Jr., Kerr, I. M. & Stark, G. M. (1994) Science 264, 1415-1421.
11. Kessler, D. S., Veals, S. A., Fu, X.-Y. & Levy, D. E. (1990) Genes Dev. 4, 1753-1765.
12. Aaronson, D. S. & Horvath, C. M. (2002) Science 296, 1653-1655.
13. Lau, J. F. & Horvath, C. M. (2002) Mt. Sinai J. Med. 69, 156-168.
14. Muller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E., Jr., Stark, G. R. & Kerr, I. M. (1993) EMBO J. 12, 4221-4228.
15. Kraus, T. A., Lau, J. F., Parisien, J. P. & Horvath, C. M. (2003) J. Biol. Chem. 278, 13033-13038.
16. Veals, S. A., Schindler, C., Leonard, D., Fu, X.-Y., Aebersold, R., Darnell, J. E., Jr., & Levy, D. E. (1992) Mol. Cell. Biol. 12, 3315-3324.
17. Qureshi, S. A., Leung, S., Kerr, I. M., Stark, G. R. & Darnell, J. E., Jr. (1996) Mol. Cell. Biol. 16, 288-293.
18. Paulson, M., Pisharody, S., Pan, L., Guadagno, S., Mui, A. L. & Levy, D. E. (1999) J. Biol. Chem. 274, 25343-25349.
19. Park, C., Lecomte, M. J. & Schindler, C. (1999) Nucleic Acids Res. 27, 4191-4199.
20. Bhattacharya, S., Eckner, R., Grossman, S., Oldread, E., Arany, Z., D'Andrea, A. & Livingston, D. M. (1996) Nature 383, 344-347.
21. Paulson, M., Press, C., Smith, E., Tanese, N. & Levy, D. E. (2002) Nat. Cell Biol. 4, 140-147.
22. Huang, M., Qian, F., Hu, Y., Ang, C., Li, Z. & Wen, Z. (2002) Nat. Cell Biol. 4, 774-781.
23. Lau, J. F., Nusinzon, I., Burakov, D., Freedman, L. P. & Horvath, C. M. (2003) Mol. Cell. Biol. 23, 620-628.
24. Rodriguez, J. J., Parisien, J. P. & Horvath, C. M. (2002) J. Virol. 76, 11476-11483.
25. Horvath, C. M. & Darnell, J. E., Jr. (1996) J. Virol. 70, 647-650.
26. Kraus, T. A., Lau, J. F., Parisien, J.-P. & Horvath, C. M. (2003) J. Biol. Chem. 278, 13033-13038.
27. Caillaud, A., Prakash, A., Smith, E., Masumi, A., Hovanessian, A. G., Levy, D. E. & Marie, I. (2002) J. Biol. Chem. 277, 49417-49421.
28. Masumi, A., Yamakawa, Y., Fukazawa, H., Ozato, K. & Komuro, K. (2003) J. Biol. Chem. 278, 25401-25407.
29. Masumi, A. & Ozato, K. (2001) J. Biol. Chem. 276, 20973-20980.
30. Decker, T., Lew, D. J., Mirkovitch, J. & Darnell, J. E., Jr. (1991) EMBO J. 10, 927-932.
31. Gu, W. & Roeder, R. G. (1997) Cell 90, 595-606.
32. Ferreira, R., Naguibneva, I., Mathieu, M., Ait-Si-Ali, S., Robin, P., Pritchard, L. L. & Harel-Bellan, A. (2001) EMBO Rep. 2, 794-799.
33. Durbin, J. E., Hackenmiller, R., Simon, M. C. & Levy, D. E. (1996) Cell 84, 443-450.
34. Friedman, R. M. (1981) Interferons: A Primer (Academic, New York).
35. Xu, M., Nie, L., Kim, S. H. & Sun, X. H. (2003) EMBO J. 22, 893-904.
36. Koyama, Y., Adachi, M., Sekiya, M., Takekawa, M. & Imai, K. (2000) Blood 96, 1490-1495.
37. Yoshida, M., Furumai, R., Nishiyama, M., Komatsu, Y., Nishino, N. & Horinouchi, S. (2001) Cancer Chemother. Pharmacol. 48, Suppl. 1, S20-S26.
38. Grozinger, C. M. & Schreiber, S. L. (2002) Chem. Biol. 9, 3-16.
39. Agalioti, T., Chen, G. & Thanos, D. (2002) Cell 111, 381-392.